Vaccine, hepatitis A


Thông tin thuốc gốc
Chỉ định và Liều dùng
Intramuscular
Active immunisation against hepatitis A
Adult: As inactivated hepatitis A virus vaccine containing 1,440 ELISA units per 1 mL: ≥16 years Primary immunisation: 1 mL as single dose. Booster dose: 1 mL 6-12 months (may be given up to 36 months) after initial dose. As inactivated hepatitis A virus (CR 326F strain) vaccine containing 50 units per 1 mL: ≥18 years Primary immunisation: 1 mL as single dose. Booster dose: 1 mL 6-18 months after initial dose; may be given 6-12 months following initial dose of other inactivated hepatitis A vaccine. As inactivated hepatitis A virus (GBM strain) vaccine containing 160 units per 0.5 mL: ≥16 years 0.5 mL as single dose. Booster dose: 0.5 mL 6-12 months (may be given up to 36 months) after initial dose.
Child: As inactivated hepatitis A virus vaccine containing 720 ELISA units per 0.5 mL: 1-15 years Primary immunisation: 0.5 mL as single dose. Booster dose: 0.5 mL 6-12 months (may be given up to 36 months) after initial dose. As inactivated hepatitis A virus containing 25 units per 0.5 mL: 1-17 years Primary immunisation: 0.5 mL as single dose. Booster dose: 0.5 mL 6-18 months after initial dose; may be given 6-12 months following initial dose of other inactivated hepatitis A vaccine.
Chống chỉ định
Hypersensitivity to hepatitis A-containing vaccine.
Thận trọng
Patient with bleeding disorders (e.g. thrombocytopenia), immunosuppression, personal or family history of febrile convulsions, chronic liver disease. Postpone vaccination in patients with acute severe febrile illness. Children. Pregnancy and lactation.
Tác dụng không mong muốn
Significant: Syncope, bleeding disorders (e.g. thrombocytopenia).
Blood and lymphatic system disorders: Lymphadenopathy.
Ear and labyrinth disorders: Otitis media.
Eye disorders: Photophobia, conjunctivitis.
Gastrointestinal disorders: Nausea, abdominal pain, diarrhoea, dysgeusia, vomiting, constipation, gastroenteritis.
General disorders and administration site conditions: Fatigue, fever, malaise, weakness; injection site reactions (e.g. induration, redness, erythema, soreness, swelling).
Investigations: Increased creatine phosphokinase.
Metabolism and nutrition disorders: Anorexia.
Musculoskeletal and connective tissue disorders: Myalgia, arthralgia, hypertonia, back pain, stiffness.
Nervous system disorders: Convulsion, dizziness, headache, drowsiness, paraesthesia, migraine, tremor, vertigo, encephalopathy.
Psychiatric disorders: Insomnia, irritability, somnolence.
Reproductive system and breast disorders: Menstrual disease.
Respiratory, thoracic and mediastinal disorders: Pharyngitis, upper respiratory tract infection, asthma, cough, nasal congestion, nasopharyngitis, rhinorrhea, rhinitis.
Skin and subcutaneous tissue disorders: Pruritus, rash, urticaria.
Vascular disorders: Hot flashes.
Potentially Fatal: Severe hypersensitivity reactions, including anaphylaxis, angioedema, bronchospasm, urticaria).
Chỉ số theo dõi
Monitor LFT, anaphylaxis and syncope for 15 minutes following administration.
Tương tác
Decreased efficacy when given with immunosuppressants (e.g. high-dose corticosteroids, cytotoxic drugs). Increased risk of bleeding or haematoma with anticoagulants.
Tác dụng
Description:
Mechanism of Action: Hepatitis A vaccine stimulates immunity against hepatitis A virus (HAV) infection by inducing production of HAV-specific immunoglobulin G (IgG and M (IgM) antibodies, resulting in humoral immunity.
Bảo quản
Store between 2-8°C. Do not freeze. Protect from light.
Any unused portions should be disposed of in accordance with local requirements.
Phân loại MIMS
Vaccin, kháng huyết thanh & thuốc miễn dịch
Phân loại ATC
J07BC02 - hepatitis A, inactivated, whole virus ; Belongs to the class of hepatitis viral vaccines.
Tài liệu tham khảo
Anon. Hepatitis A Vaccine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 09/07/2018.

Anon. Hepatitis A Virus Vaccine Inactivated. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 09/07/2018.

Buckingham R (ed). Hepatitis A Vaccines. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 09/07/2018.

Havrix Injection, Suspension (GlaxoSmithKline Biologicals SA). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 09/07/2018.

Joint Formulary Committee. Hepatitis A Vaccine. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 09/07/2018.

VAQTA Injection, Suspension (Merck Sharp & Dohme Corp.). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 09/07/2018.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Vaccine, hepatitis A từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
  • Avaxim 160U
  • Avaxim 80U Pediatric
  • Epaxal
  • Havrix 1440
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in